Risk Factors For Chyle Leak After Esophagectomy.


Journal

Journal of Ayub Medical College, Abbottabad : JAMC
ISSN: 1819-2718
Titre abrégé: J Ayub Med Coll Abbottabad
Pays: Pakistan
ID NLM: 8910750

Informations de publication

Date de publication:
Historique:
entrez: 15 1 2020
pubmed: 15 1 2020
medline: 17 4 2020
Statut: ppublish

Résumé

Chylothorax is an uncommon (3-8% risk) but potentially fatal complication of esophagectomy with poorly understood risk factors. It has a high morbidity due to loss of fluids, electrolytes, and other nutrients, loss of lymphocytes and immune dysfunction. Retrospective chart review of adult patients who underwent esophagectomy between 2009 and 2016 was performed. Cases with chyle leak were identified according to a set criteria. Clinical features, operative findings and postoperative variables were recorded and predictors of chyle leak were analyzed. During the study period, a total of 193 adult patients underwent esophagectomy of which 186 received neo adjuvant chemotherapy. The mean age was 53 years with 118 males and 74 females. Type of procedure performed was 3-stage esophagectomy in 98, Transhiatal esophagectomy in 79 and Ivor-Lewis esophagectomy in 15 patients. Chyle leak was identified in 9 (4.6%) patients. There was no significant association of chyle leak with age, gender, co-morbid, level of tumor, Neoadjuvant therapy and Type of esophagectomy. Chest drain output on postoperative day 5 was significantly predictive of chyle leak (p-value<0.05). Drain output more than 1000 on day 4 was highly suggestive of chyle leak (p-value<0.05). Day on which chest drain was removed was also found to be significantly related to chyle leak (p-value <0.05). No significant preoperative risk factors were identified for chyle leak. High chest drain output on postoperative day 5 and drain output more than 1000 on day 4 are significant predictors of chyle leak.

Sections du résumé

BACKGROUND BACKGROUND
Chylothorax is an uncommon (3-8% risk) but potentially fatal complication of esophagectomy with poorly understood risk factors. It has a high morbidity due to loss of fluids, electrolytes, and other nutrients, loss of lymphocytes and immune dysfunction.
METHODS METHODS
Retrospective chart review of adult patients who underwent esophagectomy between 2009 and 2016 was performed. Cases with chyle leak were identified according to a set criteria. Clinical features, operative findings and postoperative variables were recorded and predictors of chyle leak were analyzed.
RESULTS RESULTS
During the study period, a total of 193 adult patients underwent esophagectomy of which 186 received neo adjuvant chemotherapy. The mean age was 53 years with 118 males and 74 females. Type of procedure performed was 3-stage esophagectomy in 98, Transhiatal esophagectomy in 79 and Ivor-Lewis esophagectomy in 15 patients. Chyle leak was identified in 9 (4.6%) patients. There was no significant association of chyle leak with age, gender, co-morbid, level of tumor, Neoadjuvant therapy and Type of esophagectomy. Chest drain output on postoperative day 5 was significantly predictive of chyle leak (p-value<0.05). Drain output more than 1000 on day 4 was highly suggestive of chyle leak (p-value<0.05). Day on which chest drain was removed was also found to be significantly related to chyle leak (p-value <0.05).
CONCLUSIONS CONCLUSIONS
No significant preoperative risk factors were identified for chyle leak. High chest drain output on postoperative day 5 and drain output more than 1000 on day 4 are significant predictors of chyle leak.

Identifiants

pubmed: 31933300
pii: 5750/2765

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

506-511

Auteurs

Sadaf Batool (S)

Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Sana Amir Akbar (SA)

Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Misbah Khan (M)

Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Raza Sayyed (R)

Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Osama Shakeel (O)

Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Aamir Ali Syed (AA)

Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Shahid Khattak (S)

Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Ali Raza Khan (AR)

Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH